This announcement is a separate document:
上海礼丰律师事务所关于杭州奥泰生物技术股份有限公司2022年限制性股票激励计划授予价格调整、首次授予部分第二个归属期归属条件成就及部分限制性股票作废事项之法律意见书
Legal Opinion of Shanghai Lifeng Law Firm on Hangzhou Aotai Biotechnology Co., Ltd.\'s 2022 Restricted Stock Incentive Plan Grant Price Adjustment, Achievement of Ownership Conditions for the First Second Vesting Period, and Cancellation of Some Restricted Shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.